doi:10.1002/oby.22653 Available from: 5
(NYSE: $HIMS), a telehealth company whose stock price at one point soared more than 60% since announcing it entered the booming market for these controversial drugs
PlexusDx focuses on precision-wellness approaches that incorporate genetic predispositions and clinical evidence to help patients and providers make informed choices
Hayashi Y, Ajani JA, Correa A, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutgani M, Lin SH, Welsh J, Maru DM, Swisher SG
Outsourcing PA at $399/week (volume discounts to $299/week) saves 70% versus in-house staffing while maintaining a 99.2% clean claim rate across 800+ providers